Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.44%6.71B | 5.42%5.71B | 7.72%1.86B | -4.82%1.43B | 12.21%1.31B | 8.76%1.12B | -0.09%5.42B | 18.51%1.73B | -3.18%1.5B | -9.21%1.16B |
| Cost of revenue | 14.96%4.56B | 16.11%3.97B | 11.37%1.14B | 2.76%992.29M | 30.46%959.7M | 26.57%872.29M | -2.32%3.41B | 12.76%1.02B | -4.77%965.62M | -9.26%735.65M |
| Gross profit | 23.05%2.15B | -12.82%1.75B | 2.43%721.85M | -18.59%433.18M | -19.12%346.38M | -27.47%245.7M | 3.94%2B | 28.01%704.75M | -0.17%532.11M | -9.11%428.28M |
| Operating expense | 5.01%1.93B | 13.15%1.84B | 8.36%453.34M | 12.09%462.81M | 14.31%467.89M | 18.26%454.59M | 2.47%1.62B | 2.17%418.37M | 0.20%412.89M | 3.88%409.31M |
| Operating profit | 339.32%219.07M | -124.16%-91.54M | -6.24%268.51M | -124.86%-29.64M | -740.68%-121.52M | -357.58%-208.9M | 10.74%378.92M | 103.02%286.38M | -1.42%119.22M | -75.42%18.97M |
| Net non-operating interest income (expenses) | -210.05%-17.74M | -98.51%-5.72M | -64.19%-1.46M | -82.45%-1.38M | -96.64%-1.52M | -193.53%-1.36M | -69.09%-2.88M | -139.35%-888K | -84.88%-758K | -74.49%-773K |
| Non-operating interest income | 202.98%1.22M | 722.45%403K | 467.50%227K | 6,800.00%138K | 314.29%29K | --9K | 308.33%49K | 566.67%40K | --2K | --7K |
| Non-operating interest expense | 70.14%10.42M | 108.94%6.13M | 81.57%1.69M | 100.13%1.52M | 98.59%1.55M | 195.47%1.37M | 70.76%2.93M | 146.15%928K | 85.37%760K | 73.72%780K |
| Total other finance cost | --8.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 158.11%86K | 34.51%-148K | -57.58%-52K | -475.00%-15K | 58.54%-17K | 58.97%-64K | 34.30%-226K | 87.01%-33K | 107.84%4K | -24.24%-41K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 100.33%1.71M | -514.17M | 0 | |||||||
| Income from associates and other participating interests | -11K | |||||||||
| Special income (charges) | 69.65%-110.51M | -11,676.09%-364.07M | 242.95%3.15M | |||||||
| Less:Restructuring and mergern&acquisition | ---6.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | 1,721.62%51M | ---- | ---- | ---- | ---- | -49.76%-3.15M | ---- | ---- | ---- |
| Less:Write off | -62.50%117.41M | --313.07M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -43.97%5.62M | -4.08%10.03M | -99.82%5K | -41.99%1.54M | 30.30%3.02M | 101.03%5.46M | 814.56%10.45M | 3,265.85%2.76M | 2,507.84%2.66M | 1,323.31%2.32M |
| Income before tax | 110.17%98.22M | -347.97%-965.62M | -309.78%-611.23M | -124.35%-29.49M | -686.27%-120.03M | -370.32%-204.86M | 15.74%389.41M | 113.90%291.37M | 0.45%121.13M | -74.07%20.47M |
| Income tax | -56.83%75.85M | -14.78%175.72M | 61.41%272.33M | -124.89%-12.83M | -169.69%-34.79M | -4,059.42%-49M | 230.18%206.2M | 8,340.22%168.72M | 76.19%51.55M | -170.51%-12.9M |
| Net income | 101.96%22.36M | -722.96%-1.14B | -820.42%-883.57M | -123.95%-16.66M | -355.44%-85.25M | -267.78%-155.87M | -33.14%183.21M | -8.62%122.65M | -23.82%69.58M | -44.98%33.37M |
| Net income continuous operations | 101.96%22.37M | -722.95%-1.14B | -820.42%-883.56M | -123.95%-16.66M | -355.45%-85.25M | -267.78%-155.87M | -33.14%183.21M | -8.62%122.65M | -23.81%69.58M | -44.99%33.37M |
| Noncontrolling interests | -43.14%8.46M | 87.72%14.88M | 397.80%10.58M | -65.72%4.52M | -93.99%234K | 91.99%-449K | -58.17%7.93M | -175.44%-3.55M | 44.50%13.2M | -48.10%3.89M |
| Net income attributable to the company | 101.20%13.9M | -759.63%-1.16B | -808.53%-894.14M | -137.58%-21.19M | -389.96%-85.48M | -322.66%-155.42M | -31.28%175.28M | -2.56%126.2M | -31.41%56.38M | -44.55%29.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 101.20%13.9M | -759.63%-1.16B | -808.53%-894.14M | -137.58%-21.19M | -389.96%-85.48M | -322.66%-155.42M | -31.28%175.28M | -2.56%126.2M | -31.41%56.38M | -44.55%29.48M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 101.13%1.83 | -749.94%-161.9 | -798.33%-125.14 | -135.87%-2.88 | -383.85%-11.95 | -317.71%-21.93 | -31.77%24.91 | -3.24%17.92 | -31.72%8.03 | -44.90%4.21 |
| Diluted earnings per share | 101.13%1.83 | -761.63%-161.9 | -810.22%-125.14 | -137.10%-2.9563 | -384.98%-11.95 | -317.71%-21.93 | -31.55%24.47 | -3.08%17.62 | -30.64%7.9695 | -44.71%4.1933 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |